Search Results

Comparison of a Once-a-Day Sustained-Release Morphine Formulation with Standard Oral Morphine Treatment for Cancer Pain

Authors: Weisel J.A.; Broomhead A.; Kerr R.; Tester W.; O'Meara P.; Maccarrone C.; Bowles R.; Hodsman P.

Source: Journal of Pain and Symptom Management, Volume 14, Number 2, August 1997 , pp. 63-73(11)

Publisher: Elsevier

Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain

Authors: Gourlay G.K.; Cherry D.A.; Onley M.M.; Tordoff S.G.; Conn D.A.; Hood G.M.; Plummer J.L.

Source: Pain, Volume 69, Number 3, February 1997 , pp. 295-302(8)

Publisher: Elsevier

Kadian^TM/Kapanol^TM--A once daily morphine formulation

Authors: Broomhead A.F.; Kerr R.O.; Tester W.J.; Bowles R.L.; Maccarrone C.; Hodsman G.P.

Source: European Journal of Cancer, Volume 31, Supplement 6, November 1995 , pp. 182-182(1)

Publisher: Elsevier

Once a day (i.e. 24 hourly)Kapanol^TM, a new sustained release morphine formulation, in the treatment of cancer pain: morphine metabolite profiles

Authors: Cherry D.A.; Gourlay G.K.; Onley M.M.; Tordoff S.G.; Conn D.A.; Malden T.

Source: European Journal of Cancer, Volume 31, Supplement 6, November 1995 , pp. 184-184(1)

Publisher: Elsevier

Once a day (i.e. 24 hourly) kapanol^TM, a new sustained release morphine formulation, in the treatment of cancer pain: pharmacokinetic aspects

Authors: Gourlay G.K.; Cherry D.A.; Onley M.M.; Tordoff S.G.; Conn D.A.; Plummer J.L.

Source: European Journal of Cancer, Volume 31, Supplement 6, November 1995 , pp. 187-187(1)

Publisher: Elsevier